School of Medicine


Showing 1-10 of 99 Results

  • Samuel Ricardo Saenz

    Samuel Ricardo Saenz

    Resident in Psychiatry and Behavioral Sciences

    Bio Sam Saenz received his MD degree from UC Irvine and MPH from UC Berkeley before returning to his alma mater for psychiatry residency. His research focus is mental health disparities impacting Latino populations. His career interests include social determinants of health, community psychiatry, and addiction psychiatry.

  • Debra Safer

    Debra Safer

    Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)) at the Stanford University Medical Center

    Current Research and Scholarly Interests Primary research interests include the nature and treatment of eating disorders
    (particularly bulimia nervosa and binge eating disorder), the development and treatment of obesity, and the development and treatment of problematic eating patterns in patients following bariatric surgery.

  • Manish Saggar

    Manish Saggar

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)

    Current Research and Scholarly Interests The overarching goal of my research is to develop reliable computational methods that will allow for characterizing and modeling temporal dynamics of brain activity, without averaging data in either space or time. I firmly believe that the spatiotemporal richness in brain activity might hold the key to finding the person- and disorder-centric biomarkers. I am currently developing methods to model the temporal dynamics of brain activity in individuals with fragile X syndrome and healthy controls.

  • Ahmad Salehi Najaf Abadi

    Ahmad Salehi Najaf Abadi

    Adjunct Professor, Psych/Public Mental Health & Population Sciences

    Bio Dr. Salehi is a neurobiologist working on identifying molecular mechanisms of neurodegenerative disorders including Alzheimer's disease and Down syndrome. In this process, ​he uses pre-clinical experiments to test the effects of already-approved drugs in improving cognitive function in the mouse models with hippocampal degeneration. In 2010, he received the World Technology Award for the innovative use of mouse models of Down syndrome to identify genes responsible for cognitive disabilities. Recently, he found that increasing beta2 adrenergic signaling would improve cognitive function in a mouse model of Down syndrome. Accordingly, in a collaborative study, he is testing whether already-approved beta2-adrenergic receptor agonists can indeed improve cognitive function and reduce the severity of pathology in individuals with mild to moderate Alzheimer’s disease.

    Selected Publications

    Dang V, Medina B, Das D, Moghadam S, Martin KJ, Lin B, Naik P, Patel D, Nosheny R, Wesson Ashford J, Salehi A. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome. Biol Psychiatry. 2014 Feb 1;75(3):179-88. doi: 10.1016/j.biopsych.2013.05.024. PMID: 23827853

    Salehi A, Faizi M, Colas D, Valletta J, Laguna J, Takimoto-Kimura R, Kleschevnikov A, Wagner SL, Aisen P, Shamloo M, Mobley WC. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med. 2009 Nov 18;1(7):7ra17. doi: 10.1126/scitranslmed.3000258.​ ​PMID: 20368182
    Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006 Jul 6;51(1):29-42.​ ​PMID: 16815330

    Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC.Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
    Neuron. 2006 Jul 6;51(1):29-42.

    Links:
    Lab: www.ahmadsalehi.info
    Linkedin: https://www.linkedin.com/in/ahmadsalehi1/
    Scholar: https://scholar.google.com/citations?user=Wr3FcsEAAAAJ&hl=en

  • Katherine Sanborn

    Katherine Sanborn

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Dr Katherine Sanborn specializes in the treatment of psychiatric inpatients. She has practiced Psychiatry for more than 15 years. Dr. Sanborn has a special interests in residency education, psychotherapy training, administration and developmental psychopathology.

  • Mary Sanders, Ph.D.

    Mary Sanders, Ph.D.

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child and Adolescent Psychiatry

    Current Research and Scholarly Interests Dr. Sanders is the Program Director of the Comprehensive Care Unit at Stanford where she teaches and works with inpatients with eating disorders. She has specialized in the treatment of eating disorders for the past 25 years at Stanford. She has written extensively and presented nationally on the subject of the evaluation and treatment of eating disorders and also in the field of child abuse, specifically in the area of Munchausen by proxy.

    Dr. Sanders is also involved with an international outreach project in Ghana called Project Okurase. This project involved an annual medical health outreach in the village. The project is also creating a model village which includes the building of a medical clinic, vocational school, and homes for families that take in orphans. The project is also involved with bringing safe water, building compost toilets, and bringing solar energy to the village.